Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Ibrahim Aldeailej"'
Autor:
Mikhlid H Almutairi, Bader O Almutairi, Turki M Alrubie, Sultan N Alharbi, Narasimha R Parine, Abdulwahed F Alrefaei, Ibrahim Aldeailej, Abdullah Alamri, Abdelhabib Semlali
Publikováno v:
PLoS ONE, Vol 16, Iss 1, p e0245133 (2021)
The tumor suppressor gene TP53 and its downstream genes P21 and MDM2 play crucial roles in combating DNA damage at the G1/S cell cycle checkpoint. Polymorphisms in these genes can lead to the development of various diseases. This study was conducted
Externí odkaz:
https://doaj.org/article/fbde341b52624a8a965c1d6eb9d31b1d
Autor:
Khalid Bin Abdulrahman, Abdullah Bamosa, Abdullah Bukhari, Intisar Siddiqui, Mostafa Arafa, Ashfaq Mohsin, Mamdouh Althageel, Majed Aljuaeed, Ibrahim Aldeailej, Abdulaziz Alrajeh, Kamel Aldosari, Najat Hawsawi, Khalid Zawbaee, Saad Alsurayea
Publikováno v:
International Journal of Environmental Research and Public Health; Volume 19; Issue 18; Pages: 11798
The current study investigated the impact of different doses of Nigella sativa seeds on the symptoms, the cluster of differentiation profile group, and inflammatory markers of mild COVID-19 cases. Methods: The study was a double-blind placebo-control
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5424236394330bb1fba4a212158cba8c
https://doi.org/10.3390/ijerph191811798
https://doi.org/10.3390/ijerph191811798
Autor:
Sultan N. Alharbi, Mikhlid Almutairi, Ibrahim Aldeailej, Abdullah Al-Amri, Bader Almutairi, Narasimha Reddy Parine, Abdulwahed F. Alrefaei, Turki M. Alrubie, Abdelhabib Semlali
Publikováno v:
PLoS ONE
PLoS ONE, Vol 16, Iss 1, p e0245133 (2021)
PLoS ONE, Vol 16, Iss 1, p e0245133 (2021)
The tumor suppressor gene TP53 and its downstream genes P21 and MDM2 play crucial roles in combating DNA damage at the G1/S cell cycle checkpoint. Polymorphisms in these genes can lead to the development of various diseases. This study was conducted
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e41445bc9f77c33612cfa696dc913638
https://doi.org/10.1371/journal.pone.0245133
https://doi.org/10.1371/journal.pone.0245133
Autor:
Ahmed Almatrafi, Rebecca Anderson, Mikhlid Almutairi, Ibrahim Aldeailej, Lee Larcombe, Ramsay J. McFarlane, Nicholas Stuart, Julia Feichtinger, Jane A. Wakeman, Naif O. Alsiwiehri, Keith Griffiths
Publikováno v:
Europe PubMed Central
Oncotarget
Oncotarget
Julia Feichtinger 1 , Ibrahim Aldeailej 1,* , Rebecca Anderson 1,* , Mikhlid Almutairi 1 , Ahmed Almatrafi 1 , Naif Alsiwiehri 1 , Keith Griffiths 2 , Nicholas Stuart 1,3,5 , Jane A. Wakeman 1 , Lee Larcombe 4 and Ramsay J. McFarlane 1,5 1 North West
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::036ad8df6d0d2d888645ffd886088d07
http://europepmc.org/abstract/med/22918178
http://europepmc.org/abstract/med/22918178
Autor:
Almutairi, Mikhlid H.1 (AUTHOR) malmutari@ksu.edu.sa, Almutairi, Bader O.1 (AUTHOR), Alrubie, Turki M.2 (AUTHOR), Alharbi, Sultan N.3 (AUTHOR), Parine, Narasimha R.4 (AUTHOR), Alrefaei, Abdulwahed F.1 (AUTHOR), Aldeailej, Ibrahim5 (AUTHOR), Alamri, Abdullah4 (AUTHOR), Semlali, Abdelhabib6 (AUTHOR) malmutari@ksu.edu.sa
Publikováno v:
PLoS ONE. 1/22/2021, Vol. 16 Issue 1, p1-25. 25p.